Some genes get upregulated
Potential confounders We considered a comprehensive list of potential confounders measured at or before cohort entry, which we chose on the basis of expert and a priori knowledge
The rates are remarkably similar across all three, despite their different mechanisms: Semaglutide: Nausea approximately 18%, diarrhea approximately 12%, vomiting approximately 8% Tirzepatide: Nausea 17-22% (dose dependent), diarrhea 13-16%, vomiting 6-10% Retatrutide: Nausea 16-25% (dose dependent), diarrhea 15-22%, vomiting 8-13% The pattern holds consistently
L-Carnitine Tartrate Consider L-Carnitine Tartrate
Lyophilized powder vs
revenue for Novo Nordisk and Eli Lillys GLP-1 products using the active ingredients semaglutide and tirzepatide, beginning with the first full year of sales post-launch and through 2024